Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junlan Yang

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
World Journal of Surgical Oncology|September 14, 2013
Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapyYanyun Zhu, Jie Li, Fangfang Jing, et al.
Breast (Edinburgh, Scotland)|January 10, 2013
Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trialsBo Yang, Weiwei Shi, Junlan Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2012
Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cellsYing Li, Li Shi, Chun Han, et al.
Cell Communication and Signaling : CCS|October 18, 2023
Macrophages release IL11-containing filopodial tip vesicles and contribute to renal interstitial inflammationXiaodong Zhu, Yu Zhao, Yuqiu Liu, et al.
Oncotarget|November 8, 2017
Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patientsFan Zhang, RuiXia LingHu, XingYang Zhan, et al.
The International Journal of Biochemistry & Cell Biology|November 19, 2011
Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cellFan Zhang, Fan Feng, Pingxun Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 27, 2013
Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221Ying Li, Mei Liu, Yanjun Zhang, et al.
Environmental Pollution (Barking, Essex : 1987)|August 2, 2025
A source-oriented precise risk assessment of trace metal(loid)s in sediments of the Yangtze River BasinKuo Pang, Lu Liu, Junlan Yang, et al.
Alpha Psychiatry|September 10, 2025
Predicting Physical Aggression among Schizophrenia Patients in Rural Communities of Southwestern ChinaDongmei Wu, Tingting Liu, Quan Song, et al.
World Journal of Surgical Oncology|July 31, 2014
Breast carcinoma with choriocarcinomatous features: a case report and review of the literatureYanyun Zhu, Mei Liu, Jinyu Li, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
World Journal of Surgical Oncology|September 14, 2013
Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapyYanyun Zhu, Jie Li, Fangfang Jing, et al.
Breast (Edinburgh, Scotland)|January 10, 2013
Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trialsBo Yang, Weiwei Shi, Junlan Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2012
Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cellsYing Li, Li Shi, Chun Han, et al.
Cell Communication and Signaling : CCS|October 18, 2023
Macrophages release IL11-containing filopodial tip vesicles and contribute to renal interstitial inflammationXiaodong Zhu, Yu Zhao, Yuqiu Liu, et al.
Oncotarget|November 8, 2017
Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patientsFan Zhang, RuiXia LingHu, XingYang Zhan, et al.
The International Journal of Biochemistry & Cell Biology|November 19, 2011
Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cellFan Zhang, Fan Feng, Pingxun Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 27, 2013
Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221Ying Li, Mei Liu, Yanjun Zhang, et al.
Environmental Pollution (Barking, Essex : 1987)|August 2, 2025
A source-oriented precise risk assessment of trace metal(loid)s in sediments of the Yangtze River BasinKuo Pang, Lu Liu, Junlan Yang, et al.
Alpha Psychiatry|September 10, 2025
Predicting Physical Aggression among Schizophrenia Patients in Rural Communities of Southwestern ChinaDongmei Wu, Tingting Liu, Quan Song, et al.
World Journal of Surgical Oncology|July 31, 2014
Breast carcinoma with choriocarcinomatous features: a case report and review of the literatureYanyun Zhu, Mei Liu, Jinyu Li, et al.
Pageof 7